The prognostic value of pre-discharge exercise testing after myocardial infarction treated with either primary PCI or fibrinolysis: a DANAMI-2 sub-study
Authors:
- Nana ValeurNVNana Valeur
- Peter ClemmensenPCPeter Clemmensen
- Kari SaunamäkiKSKari Saunamäki
- Peer GrandePGPeer Grande
- 29 November 2004
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 26 (2) , 119-127
Abstract
Aims To evaluate the prognostic importance of pre-discharge maximal symptom-limited exercise testing (ET) following acute myocardial infarction (AMI) in the era of aggressive reperfusion. Methods and results In the DANAMI-2 (the second DANish trial in AMI) study, patients with ST-elevation AMI (STEMI) were randomized to primary angioplasty (PCI) or fibrinolysis. Of 1462 patients discharged alive, 1164 (79.6%) performed an ET. Primary endpoint was a composite of death and re-infarction. Patients randomized to fibrinolysis developed ST-depression to a greater extent than patients randomized to primary PCI (21.7 vs. 15.3%, P =0.007). Multivariable predictors of death and re-infarction included age, gender, diabetes, previous stroke, anterior AMI, randomization to fibrinolysis, and exercise capacity [risk ratio (RR) 0.82 (0.72–0.93); P <0.001]. ST-depression was predictive of the clinical outcome [RR 1.57 (1.00–2.48); P <0.05] in multivariable analysis, but stratified according to treatment groups there was a significant association between ST-depression and outcome in the fibrinolysis group [RR 1.95 (1.11–3.44); P <0.05], but not in the primary PCI group [RR 1.06 (0.47–2.36); P =ns]. However, the P -value for interaction was 0.15. Conclusion Exercise testing after contemporary reperfusion therapies for STEMI confers important prognostic information. Exercise capacity is a strong prognostic predictor of death and re-infarction irrespective of treatment strategy, whereas the prognostic significance of ST-depression seems to be strongest in the fibrinolysis-treated patients.Keywords
This publication has 16 references indexed in Scilit:
- A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial InfarctionNew England Journal of Medicine, 2003
- Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the danish trial in acute myocardial infarction-2 (DANAMI-2)American Heart Journal, 2003
- ACC/AHA 2002 guideline update for exercise testing: summary articleJACC, 2002
- Prognostic value of exercise testing in a cohort of patients followed for 15 years after acute myocardial infarctionEuropean Heart Journal, 2001
- Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999JACC, 2000
- Danish Multicenter Randomized Study of Invasive Versus Conservative Treatment in Patients With Inducible Ischemia After Thrombolysis in Acute Myocardial Infarction (DANAMI)Circulation, 1997
- Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-baseThe Lancet, 1995
- Prediction of mortality following hospital discharge after thrombolysis for acute myocardial infarction: is there a need for coronary angiography?European Heart Journal, 1993
- Predischarge maximal exercise test identifies risk for cardiac death in patients with acute myocardial infarctionThe American Journal of Cardiology, 1990
- Application of meta-analysis using an electronic spread sheet to exercise testing in patients after myocardial infarctionThe American Journal of Medicine, 1987